Enveda is a biotechnology company unravelling compounds in nature that can be used to discover new drugs. Enveda was founded in 2019 by Viswa Colluru, a PhD in cellular and molecular biology who is deeply passionate about bringing life changing drugs to market. Using machine learning, computing power and human understanding, Enveda has created a chemical ‘search engine’ which attempts to tackle some of the toughest problems in drug discovery by finding answers in natural compounds.
A chat with Viswa Colluru
Kinnevik’s Investment Director Christian Scherrer sat down with Enveda's founder and CEO Viswa Colluru for a deep dive into the company's work, and what it might mean for the future of drug discovery and beyond.